Founded in October 2010, as a spin-off of the Liège University in Belgium, Artialis became a first-mover biotech company specialized in the development and clinical application of biomarkers-based immunoassays and trials. To date, ARTIALIS is a niche Contract research Organization company highly specialized in the management of preclinical and clinical studies in the field of musculoskeletal disorders and rheumatic diseases. Artialis offers customized solutions for its clients, from preclinical (in vitro and in vivo) to post-marketing clinical phase and propose a large panel of clinical, imaging and biochemical markers useful to support drug development. Artialis' activities are organized in three departments so called, Preclinical, Clinical and Biotesting.